PTGX · NASDAQ · Biotechnology

Protagonist Therapeutics (PTGX)

Discovers peptide medicines and earns collaboration economics from partnered ICOTYDE and rusfertide.

$145.07
After hours−0.05 (−0.03%)
At close$145.12(+0.10%)